ClinVar Miner

Submissions for variant NC_000019.9:g.(?_1207072)_(1215467_?)del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV004581053 SCV005063597 pathogenic Peutz-Jeghers syndrome 2022-10-27 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the STK11 protein in which other variant(s) (p.Leu67Pro) have been determined to be pathogenic (PMID: 9428765, 9837816, 9887330, 10441497, 11389158, 15987703). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Studies have shown that this variant results in partial skipping of exon 1 and introduces a premature termination codon (Invitae). The resulting mRNA is expected to undergo nonsense-mediated decay. This variant has not been reported in the literature in individuals affected with STK11-related conditions. This variant results in the deletion of part of exon 1 (c.160_291-2949delinsA) of the STK11 gene. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.